Wu Linrui, Zhao Binxin, Deng Zixin, Wang Bin, Yu Yi
Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Hubei Clinical Center and Key Laboratory of Intestinal and Colorectal Disease, School of Pharmaceutical Sciences, Wuhan University, 185 East Lake Road, Wuhan 430071, China.
State Key Laboratory of Non-Food Biomass and Enzyme Technology, Guangxi Academy of Sciences, Nanning 530007, China.
Hortic Res. 2023 Dec 13;11(1):uhad259. doi: 10.1093/hr/uhad259. eCollection 2024 Jan.
Protoberberine alkaloids are a group of tetracyclic isoquinoline compounds known for their well-established antimicrobial and anti-inflammatory properties. The richness and diversity of protoberberine alkaloids accumulated in the genus necessitate a comprehensive examination of the biosynthetic machinery to understand their ecological significance. Here, from we identified CcCYP719A1, which could install a methylenedioxy bridge on either ring A or ring D of the protoberberine backbone, thus diverging metabolite flux towards the biosynthesis of various protoberberine components. We also obtained CcCYP719A2 and CcCYP719A3, which underwent positive selection after diverging from CcCYP719A1 and maintained specific catalytic activity on ring D. Further, we resolved the biosynthetic pathway of jatrorrhizine by identifying two demethylases, which could also modulate protoberberine composition by removing the C-3 methyl group and methylenedioxy bridge of ring D, allowing demethylated metabolites to be redirected into different routes. Moreover, we characterized 2--methyltransferase CcOMT1 and flavin-dependent oxidase CcTHBO, respectively responsible for the commonly observed 2--methylation and aromatic ring-C assembly in protoberberine alkaloids. Overall, this study reveals an interconnected metabolite network from which diverse protoberberine alkaloids originate. It provides valuable insights into the existence of undiscovered protoberberine components, and paves the way for the targeted production of desired protoberberine components for potential therapeutic development.
原小檗碱生物碱是一类四环异喹啉化合物,以其公认的抗菌和抗炎特性而闻名。该属中积累的原小檗碱生物碱的丰富性和多样性需要对生物合成机制进行全面研究,以了解它们的生态意义。在这里,我们鉴定出CcCYP719A1,它可以在原小檗碱骨架的A环或D环上安装一个亚甲二氧基桥,从而使代谢物通量转向各种原小檗碱成分的生物合成。我们还获得了CcCYP719A2和CcCYP719A3,它们从CcCYP719A1分化后经历了正选择,并在D环上保持了特定的催化活性。此外,我们通过鉴定两种去甲基化酶解析了药根碱的生物合成途径,这两种酶还可以通过去除D环的C-3甲基和亚甲二氧基桥来调节原小檗碱的组成,使去甲基化的代谢物转向不同的途径。此外,我们分别鉴定了2'-甲基转移酶CcOMT1和黄素依赖性氧化酶CcTHBO,它们分别负责原小檗碱生物碱中常见的2'-甲基化和芳香环-C组装。总的来说,这项研究揭示了一个相互关联的代谢物网络,各种原小檗碱生物碱都起源于此。它为未发现的原小檗碱成分的存在提供了有价值的见解,并为潜在治疗开发中靶向生产所需的原小檗碱成分铺平了道路。